国产中文无码av每日更新在线观看, 亚洲天堂中文字幕一区二区三区免费, 国产口爆吞精在线观视频-黄色国产, 92福利-国内精品久久久久久99,亚洲成AV人A片不卡无码,浪潮AV无码专区,老熟女败火白浆,中文字幕日产av,色情日本免费看大片

更新于 今天

TCE資深部長

5-9萬
  • 成都雙流區(qū)
  • 10年以上
  • 博士
  • 全職
  • 招1人

職位描述

生物藥研發(fā)TCE抗體
Huiyu Research Institute is seeking a group leader in TCE to help us advance in immuno-oncology and to develop therapeutic hypotheses from target identification,pathway validation, therapeutic development and beyond. The candidate must be independent and goal oriented, and able to efficiently lead teams and complete multiple projects in parallel. The position will require creativity, resourcefulness, and adaptability. The candidate will be responsible for the direction and execution of projects, including novel assay development, in vitro proof-of concept, and in vivo translational studies, and aligning the scientific plan with corporate objectives. We are searching for enthusiastic, innovative, and highly motivated individuals who are comfortable working in a fast-paced entrepreneurial environment.
Responsibilities
1、Design experimental plans for pathway validation and target identification,including assay development in vitro and in vivo, in collaboration with the scientific team.
2、Execute experiments, interpret and validate results, and communicate data to scientific team and executive management.
3、Lead and collaborate with other scientists and research associates to achieve company objectives.
4、 Manage external research relationships with academic and commercial partners.
Qualifications
1、PhD or equivalent in the biological sciences, bioengineering, or related field.
2、5+ years of relevant laboratory experience, in academic, pharmaceutical or biotechnology settings.
3、Demonstrated ability in working with highly skilled teams in a fast-paced, entrepreneurial and technical setting.
4、Immunologist with a focus on target discovery. Research experience in immune oncology.
5、Strong experimental skills, especially assay development (in vitro & in vivo models), cell and molecular immunology. Expertise in multi-color flow cytometry immune cell phenotyping, tissue isolation techniques and assays.
6、Motivated and curious, experienced working with highly technical projects and personnel.
7、 Highly adaptable and responsive to technical and business opportunities and needs – comfortable delivering against challenging commitments.
8、Excellent communication and presentation skills, capable of conveying technical information in a clear and thorough manner.
9、PhD or equivalent in the biological sciences, bioengineering, or related field.
10、5+ years of relevant laboratory experience, in academic, pharmaceutical or biotechnology settings.
11、Demonstrated ability in working with highly skilled teams in a fast-paced, entrepreneurial and technical setting.

工作地點

成都雙流區(qū)四川匯宇海玥醫(yī)藥科技有限公司

職位發(fā)布者

牟女士/HRBP

剛剛活躍
立即溝通
公司Logo四川匯宇海玥醫(yī)藥科技有限公司
四川匯宇制藥股份有限公司生產(chǎn)基地位于四川省內(nèi)江經(jīng)濟技術(shù)開發(fā)區(qū)內(nèi),占地面積10萬平方米,項目總投資10億元人民幣,致力于高端抗腫瘤藥物的研發(fā),生產(chǎn)和銷售。公司在四川成都雙流區(qū)“天府國際生物城”設(shè)立全球創(chuàng)新藥研發(fā)中心,將打造抗體抗癌創(chuàng)新藥物研發(fā)總部及產(chǎn)業(yè)化基地,建設(shè)包括從事靶向抗腫瘤小分子化學(xué)藥和大分子生物藥研發(fā)、中試及產(chǎn)業(yè)化的研發(fā)中心,占地面積60畝,規(guī)劃建筑面積88000平方米,可容納1500名研發(fā)人員,計劃在2022年建成運行。公司以科技創(chuàng)新為導(dǎo)向的發(fā)展理念,不斷完善小分子化學(xué)藥物和單克隆抗體生物藥物兩個技術(shù)平臺,開發(fā)抗腫瘤領(lǐng)域的創(chuàng)新藥物,公司一期項目可年產(chǎn)3000萬瓶抗癌針劑,實現(xiàn)年產(chǎn)值25億元人民幣。公司的抗癌針劑于2014年通過英國GMP認證,并于同年順利通過中國GMP認證。2015年7月公司獲得歐盟藥品放行資質(zhì),公司生產(chǎn)的抗癌針劑已經(jīng)在伊麗莎白女王醫(yī)院、皇家倫敦醫(yī)院和劍橋大學(xué)附屬醫(yī)院等1200多家歐盟醫(yī)院作為一線抗癌藥物大規(guī)模使用。公司在美國、英國、法國、澳大利亞、加拿大、中國香港等全球80多個國家和地區(qū)建立了銷售渠道并啟動了當?shù)氐乃幤纷怨ぷ?,已逐步建立并完善遍布全球的銷售網(wǎng)絡(luò)。同時以致力于改善人類健康為崇高宗旨,以‘關(guān)愛生命,追求卓越,簡單誠信’為價值導(dǎo)向,力爭把公司打造成一家受人尊敬的國際化制藥企業(yè)。
公司主頁